All Type of News
Zuellig Pharma Korea blasted for unfair contract terms
The unfair contract terms between Zuellig Pharma Korea (ZPK) and associate wholesalers, including ZPK's dubious third-party logistic patterns, have reignited criticism from the overall wholesaling industry.
Market ...
SPA and CCEJ to raise OTC drug issue on public debate.
A public debate may be visualized on the OTC drug sales at general supermarket stores under the arrangement by two opposing groups, the Seoul Pharmaceutical Association (SPA) and the Citizen's Coalition for Economic J...
Positive list system to restrict drug demand will hurt pharmaceutical sectorThe government is implementing its new drug pricing policy, the so-called positive list system, to exclude drugs of low quality from the insurance-covered drug lists, but this w...
|
National Assembly to convene FTA public hearing over pharmaceutical sector
The National Assembly's Health and Welfare Committee decided to hold its public hearing on June 18 over controversial issues of pharmaceuticals raised from a free trade agreement reached between Korea and the United S...
Restructuring of domestic drug makers foreseeable
Influenced by a free trade accord between Korea and the United States and a new public health insurance regulation, the so-called positive list system, a number of Korean drug makers are likely to accelerate their res...
KFDA to restrict purchase of cold remedy
The Korea Food and Drug Administration announced on June 5 that customers will be unable to buy more than one or two boxes of cold medicine containing ephedrine (equivalent to 720 mg) at one time from a pharmacy.
...
KFDA freely allows any institutes to take clinical studies.
So far the KFDA has controlled the designation of the clinical study institute, which will be no longer effected and therefore any institutes can get easy entry into the clinical research activities.
The KFDA anno...
Bayer, Schering Korea to be incorporated next year
Bayer HealthCare Korea and Schering Korea plan to integrate their business unit from January 1 next year.
The 2006 acquisition of Schering was the largest purchase in Bayer's history. The takeover led to the format...
Shinshin enjoying Liesend, a removal drug for hair lice .
According to a reliable industrial source on June 4, the sales of "Liesend Plus" of Shin Shin Pharmaceutical Inc. for the hair lice removal remedy, showed an explosive figure in the market.
A drug wholesaler said ...
FTA will hurt pharmaceutical sector
A local lawyer said Korea's pharmaceutical sector is expected to face an inevitable blow if a U.S.-Korea free trade agreement goes through.
The worst scenario is based upon the fact that the Korean government will ...
